Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A Sippet Analysis

Frits Rosendaal, MD PhD, Roberta Palla, PhD, Isabella Garagiola, PhD, Piermannuccio Mannucci, MD, Flora Peyvandi, MD PhD

Blood (2016) 128 (22): 325.

https://doi.org/10.1182/blood.V128.22.325.325

Published: 2016

Journal Articles

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Flora Peyvandi, MD PhD, Antonino Cannavò, MD, Isabella Garagiola, PhD, Roberta Palla, PhD, Frits Rosendaal, MD PhD, Piermannuccio Mannucci, MD

Blood (2016) 128 (22): 330.

https://doi.org/10.1182/blood.V128.22.330.330

Published: 2016

Journal Articles

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Flora Peyvandi, MD PhD, Pier Mannuccio Mannucci, MD, Isabella Garagiola, PhD, Mohsen Elalfy, MD, Amal El-Beshlawy, MD, Madatha V. Ramanan, MD, Peyman Eshghi, MD, Suresh Hanagavadi, Ramabadran Varadarajan, MD, Mehran Karimi, MD, Mamta V. Manglani, MD, Cecil Ross, MD, Guy Young, MD, Tulika Seth, MD, Shashikant Apte, MD FRCPA, Dinesh M. Nayak, MD, Adriana C. Sandoval Gonzales, MD, Elena Santagostino, MD PhD, Maria Elisa Mancuso, MD PhD, Johnny N. Mahlangu, MD, Santiago Bonanad, PhD, Monica Cerqueira, MD, Nadia P. Ewing, MD, Christoph Male, MD MSC, Tarek Owaidah, MD FRCPA, Veronica Soto Arellano, MD, Nathan L. Kobrinsky, MD FRCP, Suvankar Majumdar, MD, Rosario Perez Garrido, MD, Anupam Sachdeva, Mindy Simpson, MD FAAP, Mathew Thomas, Ezio Zanon, MD, ALI Bulent Antmen, Kaan Kavakli, MD, Marilyn Manco-Johnson, MD, Monica Martinez, MD, Esperanza Marzouka, MS, PS, Maria Gabriella Mazzucconi, MD, Daniela Neme, MD, Angeles Palomo Bravo, MD, Rogelio Paredes Aguilera, MD, Alessandra Nunes Loureiro Prezotti, MD, Schmitt Klaus, MD, Brian M. Wicklund, MD MPH, Bulent Zulfikar, MD, Rosendaal R. Frits, MD PhD

Blood (2015) 126 (23): 5.

https://doi.org/10.1182/blood.V126.23.5.5

Published: 2015

Journal Articles

Type of Factor VIII Product as Inhibitor Risk Factor in Patients with Severe Hemophilia A and Null Mutations.

Maria Elisa Mancuso, MD, PhD, Pier Mannuccio Mannucci, MD, Angiola Rocino, MD, Isabella Garagiola, PhD, AnnaRita Tagliaferri, MD, Maurizio Margaglione, MD, Elena Santagostino, MD, PhD

Blood (2009) 114 (22): 3500.

https://doi.org/10.1182/blood.V114.22.3500.3500

Published: 2009

Journal Articles

Non-Sense-Mediated mRNA Decay in ADAMTS13 Gene Caused by 29 Nucleotide Deletion.

Isabella Garagiola, PhD, Silvia Lavoretano, Hale Oren, Martina Bohm, Pier Mannuccio Mannucci, Flora Peyvandi

Blood (2006) 108 (11): 1061.

https://doi.org/10.1182/blood.V108.11.1061.1061

Published: 2006

Journal Articles

The First Deletion Mutation in the TSP1-6 Repeat Domain of ADAMTS13 Leads to a Secretion Defect.

Flora Peyvandi, MD, PhD, Silvia Lavoretano, PhD, Roberta Palla, PhD, Isabella Garagiola, PhD, Carla Valsecchi, PhD, Rossana Lombardi, PhD, Maria T. Canciani, PhD, Pier M. Mannucci, MD

Blood (2005) 106 (11): 3960.

https://doi.org/10.1182/blood.V106.11.3960.3960

Published: 2005

Journal Articles

Localization and Function of Platelet ADAMTS-13.

Flora Peyvandi, MD, PhD, Isabella Garagiola, PhD, Andrea Artoni, MD, Rossana Lombardi, PhD, Roberta Palla, PhD, Raimondo De Cristofaro, MD, Pier Mannuccio Mannucci, MD

Blood (2005) 106 (11): 3967.

https://doi.org/10.1182/blood.V106.11.3967.3967

Published: 2005

NARROW

Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A Sippet Analysis

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Type of Factor VIII Product as Inhibitor Risk Factor in Patients with Severe Hemophilia A and Null Mutations.

Non-Sense-Mediated mRNA Decay in ADAMTS13 Gene Caused by 29 Nucleotide Deletion.

The First Deletion Mutation in the TSP1-6 Repeat Domain of ADAMTS13 Leads to a Secretion Defect.

Localization and Function of Platelet ADAMTS-13.

Email alerts

ASH Publications

American Society of Hematology

Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A Sippet Analysis

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Type of Factor VIII Product as Inhibitor Risk Factor in Patients with Severe Hemophilia A and Null Mutations.

Non-Sense-Mediated mRNA Decay in ADAMTS13 Gene Caused by 29 Nucleotide Deletion.

The First Deletion Mutation in the TSP1-6 Repeat Domain of ADAMTS13 Leads to a Secretion Defect.

Localization and Function of Platelet ADAMTS-13.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only